Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Cell Biochem ; 116(12): 2903-14, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26018553

RESUMO

Previously, we showed that Mekk1 translocates to the nucleus, interacts with tumor suppressor protein p53, and co-represses PKD1 transcription via an atypical p53 binding site on the minimal PKD1 promoter (JBC 285:38,818-38,831, 2010). In this study, we report the mechanisms of Mekk1 nuclear transport and p53 binding. Using GFP-linked constitutively active-Mekk1 (CA-Mekk1) and a deletion strategy, we identified a nuclear localization signal (HRDVK) located at amino acid (aa) residues 1,349-1,353 in the C-terminal Mekk1 catalytic domain. Deletion of this sequence in CA-Mekk1 and full-length Mekk1 significantly reduced their nuclear translocation in both HEK293T and COS-1 cells. Using co-immunoprecipitation, we identified an adjacent sequence (GANLID, aa 1,354-1,360) in Mekk1 responsible for p53 binding. Deletion of this sequence markedly reduced the interaction of Mekk1 with p53. Mekk1 does not appear to affect phosphorylation of Ser15, located in the Mdm2 interaction site, or other Ser residues in p53. However, Mekk1 mediates p53 protein stability in the presence of Mdm2 and reduces p53 ubiquitination, suggesting an interference with Mdm2-mediated degradation of p53 by the ubiquitin-proteasome pathway.


Assuntos
MAP Quinase Quinase Quinase 1/metabolismo , Sinais de Localização Nuclear/metabolismo , Proteínas Proto-Oncogênicas c-mdm2/metabolismo , Canais de Cátion TRPP/metabolismo , Proteína Supressora de Tumor p53/metabolismo , Animais , Sítios de Ligação , Células COS , Chlorocebus aethiops , Células HEK293 , Humanos , MAP Quinase Quinase Quinase 1/genética , Sinais de Localização Nuclear/genética , Complexo de Endopeptidases do Proteassoma/metabolismo , Ligação Proteica , Estabilidade Proteica , Proteínas Proto-Oncogênicas c-mdm2/genética , Canais de Cátion TRPP/genética , Proteína Supressora de Tumor p53/genética , Ubiquitinação/genética
2.
Nat Prod Commun ; 7(9): 1203-8, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23074909

RESUMO

Bitter melon (Momordica charantia) seed extracts (BMSE) have been used as traditional medicine for treating various ailments, although in many cases, the active component(s) are unidentified. In this study, bitter melon seeds were extracted in water, ethanol, or ethanol: water (1:1). The aqueous seed extracts (BMSE-W) exhibited marked cytotoxicity towards human embryonic kidney 293T (HEK293T) and human colon tumor 116 (HCT1116) cells. The activity in BMSE-W was unaffected by heat and proteinases treatments, and eluted in the total volume of size-exclusion HPLC, suggesting the small, organic nature of the active component(s). Gas chromatographic-mass spectrometic (GC-MS) analysis of the HPLC fractions identified methoxy-phenyl oxime (MPO) as a major active component. Acetophenone oxime, a commercially available structural homolog of MPO, demonstrated cytotoxicity comparable with that of the BMSE-W. The oxime functional group was found to be critical for activity. Increased poly-(ADP-ribose)-polymerase and beta-actin cleavage, and chromatin condensation observed in treated cells suggested apoptosis as a plausible cause for the cytotoxicity. This study, for the first time, identified a cytotoxic oxime in BMSE-W.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Momordica charantia/química , Extratos Vegetais/farmacologia , Apoptose/efeitos dos fármacos , Células HCT116 , Células HEK293 , Humanos , Sementes/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...